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Presence of a natriuretic factor in urine of normal men
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Presence of a natriuretic factor in urine of normal men undergo-
ing water immersion. Immersion of normal subjects in water to the
neck (NT) results in a redistribution of blood volume, relative
central hypervolemia, and a significant natriuresis which is equal
in magnitude to that produced by 10% expansion of the extracellu-
lar fluid volume by isotonic saline. The natriuresis of NT is inde-
pendent of changes in GFR and is not prevented by the administra-
tion of DOCA. The present study was undertaken to determine
whether the NI natriuresis is associated with increased activity of
the natriuretic factor (NF) that has been observed in volume-
expanded dogs and uremic dogs and patients. Twelve normal
subjects were studied following overnight water restriction for 10
hr. Each subject was studied under control conditions, during NI
in the seated position, and at the same time of day. UNaV, while
remaining constant during control studies, increased significantly
during NI. Bioassays for natriuretic activity were performed in
rats by using urine fractions from NI and control studies. The NI
fractions in the test animals resulted in significant increments in
both UNaY (1.27 0.28pEq/min) and FEE. (1.39 0.21%) (P <
0.001 for both). With the control fractions, there was no significant
change in UNaV, and there was a small increment in FEN3 (0.70
0.25%; P cc 0.05). The natriuresis of NI, thus, is associated with
increased activity of natriuretic factor. The demonstration of
increased NF in normal subjects during a period of increased
sodium excretion strengthens the possibility that the natriuretic
factor may participate in the regulation of sodium excretion and of
sodium homeostasis.
Presence d'un facteur natriurétique dans l'urine de sujets nor-
maux soumis Li l'immersion. L'immersion de sujets normaux jus-
qu'au cou (NI) a pour consequence une redistribution du volume
sanguin, une hypervolemie centrale relative et une natriurCse sig-
nificative qui est égale, en importance, a celle produite par une
expansion de 10% du volume des liquides extracellulaires au
moyen de solute sale isotonique. La natriurése de NI est indepen-
dante des modifications du debit de filtration glomdrulaire et n'est
pas empéchéc par l'administration préalable de DOCA. Ce travail
a pour but de savoir si Ia natriurèse d'immersion est associée a une
augmentation de l'activité du facteur natriurétique (NF) tdlle
qu'elle a été observee chez des chiens soumis a une expansion ou
des hommes ou des ehiens urémiques. Douse sujets normaux ont
été étudiés aprés 10 hr de suppression des boissons. Chaque sujet a
étd étudié dans des conditions contrOles et pendant Ia NI, en
position assise et au même moment de lajoumée. UNaV augmenté
significativement pendant Ia NI alors qu'it dtait constant pendant
les périodes contrôles. Le dosage biologique de l'activité natriuré-
tique a été réalisé ches des rats, a partir des fractions de l'urine
recueillie pendant NI et pendant les pdriodes contrôles. Les frac-
tions provenant de NI ont eu pour effet une augmentation signifi-
cative de UNaV (1,27 0,28jsEqlmin)et FENa(l,39 0,21%)ehez
les animaux utilises. Les fractions contrOles n'ont pas eu d'effet
significatif sur UNaV et ont determine une nette augmentation de
FE53 (0,7 0,25%; P cc 0,05). La natriurése de NI est done
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associee a l'augmentation d'activite du facteur natriuretique. La
mise en evidence d'une augmentation du facteur natriuretique
ehes les sujets nonnaux an eours d'une augmentation de
l'exerétion du sodium renforee Ia possibilitC que ce facteur puisse
participer a la regulation de l'excrétion du sodium et a
l'homéostasie du sodium.
Immersion of normal subjects to the level of their
neck in water (NI) results in a significant and repro-
ducible natriuresis [1-4]. In association with the
increase in sodium excretion, there is a redistribution
of blood volume with relative "central hypervole-
mia" and a suppression of renin and aldosterone
concentrations in the blood [5]. The water immer-
sion natriuresis has been shown to be independent of
changes in glomerular filtration rate (GFR) [6] and
has been shown to persist, although in a blunted
fashion, when a potent mineralocorticoid hormone is
administered in pharmacologic doses [2]. After ces-
sation of water immersion, the natriuresis subsides;
in most studies, however, the rate of fall of UNaV is
slow [2, 6]. The latter observation opens the possibil-
ity that a humoral factor, rather than hemodynamic
and/or neurogenic mechanisms, is involved in
mediating the natriuresis.
The recent demonstration of a natriuretic factor in
the serum and urine of patients and dogs with chron-
ic uremia [7, 8], as well as in that of normal dogs
undergoing mineralocorticoid "escape" [9, 10],
raised the possibility that such a factor might also
participate in the natriuresis of immersion. The cur-
rent study was undertaken to assess whether the
natriuresis induced in normal man by immersion was
associated with increased levels of natriuretic factor.
Methods
Twelve, healthy, male subjects between the ages
of 18 and 38 years were studied. None had a history
of renal disease, hypertension, cardiovascular dis-
ease, or diabetes. At the time of study, all subjects
were ingesting a regular home diet. All subjects were
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studied twice: a) under control conditions, and b)
during water immersion to the level of the neck. The
two studies were separated by an interval of at least
three days. The protocol on the two experimental
days was carried out as follows. Following 10 hr of
overnight fluid restriction, the subject was instructed
to sit quietly for 1 hr. At 0800, after voiding and
completely emptying his bladder, the subject once
again assumed the seated position for 6 hr. To main-
tain an adequate urine flow, 200 ml of water were
administered orally every hour during each study.
During the control study, the subject sat quietly
outside the immersion tank for the 6-hr period. Dur-
ing the immersion study, the subject sat outside the
tank for 1 hr (pre-study period), immersed in water to
the neck for 4 hr (immersion period), and again
outside the tank for 1 hr (recovery period).
During the control and the immersion studies,
each subject voided spontaneously at hourly inter-
vals. During immersion, the subject stood briefly on
a platform in the immersion tank to void. Sodium,
potassium, and creatinine were measured in 5 to 10-
ml aliquots of the hourly urine collections. The
remainder of the hourly urine collections was pooled
and frozen for subsequent fractionation and assay.
Venous blood was collected at the beginning and end
of each study for determination of sodium, potas-
sium, and creatinine concentrations. All subjects
were weighed at the beginning and completion of
each study.
Immersion was carried out in a waterproof tank,
described in detail previously [1]. A constant water
temperature of 34.5 0.5°C was maintained by two
heat exchangers with a combined output of 13,500
BTUIhr and was controlled by an adjustable temper-
ature-calibrated control meter. Both heat exchangers
and control meter derived input from two thermis-
tors immersed at different water levels.
The 4-hr urine sample from each subject was frac-
tionated by a method previously described [8]. The
total volume of urine was concentrated by lyophiliza-
tion (model 5012, Refrigeration for Science, Inc.,
Island Park, N.Y.) to a volume of about 50 ml. After
centrifugation at 4°C for 10 mm at 1,800 g (PR-J
centrifuge, DamonIIEC Division, Damon Corp.,
Needham Heights, Mass.), two 20 to 25-ml aliquots of
the supernate, each equivalent to approximately a 2-
hr sample of the original urine, were applied to two
identical 2.5 X 95-cm columns packed with Sepha-
dex G-25 (fine grade, Pharmacia Fine Chemicals,
Inc., Piscataway, N.J.). Elution was carried out at
4°C by gravity with a solution of 10 mM ammonium
acetate at a pH of 6.8. The effluent solution (10 tubes
of 12 ml each) which appeared immediately after the
salt peak, and which previously has been shown to
contain the inhibitor of sodium transport in the urine
of patients [8] and dogs [91, was collected from both
columns, pooled, lyophilized to dryness, reconstitut-
ed in 2 ml of distilled water, and stored at —80C
until the day of assay. Thus, each milliliter of sample
was equivalent to the amount of urine excreted in 2
hr.
The activity of the urine fraction from each indi-
vidual study was tested in a rat assay preparation
using animals with a single remnant kidney. The
technique employed was identical to that described
previously for the assay of natriuretic factor in urine
fractions from human subjects and dogs [7, 9]. The
rationale for the use of rat with a reduced nephron
population as the assay animal is based on the
increased sensitivity of these animals to the natri-
uretic factor, as has been reported recently [11]. In
brief, the urine fraction was adjusted to a pH of 7.4,
and the sodium and potassium concentrations were
adjusted to 140 and 4 mEq/liter, respectively. The
natriuretic activity of each sample was then tested by
infusing 1 ml of fraction through a jugular venous
catheter over a 10-mm period and comparing the
average pre- and post-infusion values for GFR, abso-
lute sodium excretion rate (UNaV), and fractional
sodium excretion (FENa). The preinfusion values rep-
resent the average of the two consecutive 10-mm
clearance periods obtained immediately before injec-
tion of the fraction. The postinfusion values repre-
sent the average of six consecutive 10-mm clearance
periods obtained immediately after completion of the
infusion. GFR was measured in the rat by the clear-
ance of '4C-inulin. All fractions were adjusted and
tested by a single person who had no knowledge of
the origin of the sample being assayed.
Radioactive inulin was determined in 25 to 50-pd
samples of urine and plasma diluted in 10 ml of
Aquasol solution (New England Nuclear, Boston,
Mass.). The samples were counted in a Tri-Carb
liquid scintillation spectrometer (model 3330, Pack-
ard Instrument Co., Inc., Downers Grove, Ill.).
Sodium and potassium were measured with a flame
photometer (model 143, Instrumentation Labora-
tory, Inc., Lexington, Mass.), and the pH of the
solution and fractions during their preparation was
measured with a glass electrode with a pH meter
(model PHM 26, London Co., Cleveland, Oh.). Cre-
atinine was measured by a modification of the meth-
od of Bonsnes and Taussky [12] by using an autoana-
lyzer (model AAII, Technicon Instruments Corp.,
Tarrytown, N.Y.).
In the presentation of the data, mean values are
followed by the standard error of the mean as an
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index of dispersion. Data were evaluated statistical-
ly, where appropriate, by a paired t analysis or by
two-factor analyses of variance for experiments hav-
ing repeated measurements on the same subject [131.
If a significant effect was detected, the Fisher's least
significant difference test was used to determine
which treatment means were significantly different
[131. Differences with P < 0.05 were considered
significant.
Permission for the study was obtained from each
subject after a detailed description of the procedure
and of the potential complications. The protocol was
approved by the Human Experimentation Commit-
tees of the University of Miami School of Medicine
and the Miami Veterans Administration Hospital and
was in compliance with the principles set forth in the
Declaration of Helsinki.
Results
Functional studies of normal subjects undergoing
water immersion. Group data for the 12 subjects
during the control study and during 4 hr of water
immersion are shown in Table I and Figure 1. During
the control study, urinary flow rate, endogenous cre-
atinine clearance, and sodium and potassium excre-
tion rates remained constant. The mean values for
UNaV for the group during the hourly urine collec-
tions ranged from 95 to 1 lOp Eq/mm. Water immer-
sion to the neck resulted in an immediate increase in
urinary flow rate and in a highly significant increase
ifl UNaV from an average of l04tEq/min to 252, 242,
and 263 tEq/min during hours 2, 3, and 4 of immer-
sion, respectively (P < 0.001). After completion of
the immersion period, return to quiet sitting for 1 hr
was associated with a prompt and significant
decrease in UNaV (P < 0.001 for recovery vs. the
final hour of immersion).
Table 1. Urinary excretory patterns of norma! subjects dunng control conditions and while undergoing immersiona
Group Prestudy
Hours
1 2 3 4 Recovery
V, mi/mm Control
Immersion
1.6 0.4
3.1 1.0
2.1 0.5
5.0
1.8 0.5
6.1 10
2.1 0.4
3.6 0•5b
2.2 0.4
3•5 0.4'
2.5 0.5
1.5 02b
UNaV, p.Eqlmin Control
Immersion
95 15
104 16
97 17
136 23
109 19
252 46b
110 22
242 35'
110± 19
263 34c
108 20
137 20
UKV, p.Eqlmin Control
Immersion
50 9
44 7
59 8
79 Il 66 7125 20b 73 1!100±10 76 1190 12 67 943 6
Cer, mi/mm Control
Immersion
121 5
132 11
120 8
141 19
124±8
148 12
124 8
135 7
122 7
135 8c
119 7
115 10
a Values are the mean SEM of 12 studies.
b P <0.05. (differences from control).
P < 0.005 (differences from control).
Immersion
I, I,300
200
a.
>
z
100
1.5
1.0
w
U-
0.5
NS
NS/
ap <0.01 compared to control
I I I I
Prestudy 1 2 3 4 Recovery
Hours
Fig. 1. Effect of water immersion on absolute (UNaV) andfraction-
al (FEN) sodium excretion rates in 12 normal subjects. Immersion
resulted in a progressive increase in both UNaV and FENa begin-
ning with the second hour of immersion. Cessation of immersion
was associated with a prompt decrease in both UNaV and FENaas
compared with the final hour of immersion (P < 0.005). Results
are the mean SEM of 12 subjects.
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FENa increased during immersion from 0.54
0.06% in the prestudy period to 1.37 0.14% during
hour 4 of immersion (P <0.001) (Fig. 1). During the
postimmersion recovery period, FENa declined sig-
nificantly from 1.37 0.14% to 0.88 0.13 (P <
0.005 for recovery vs. the final hour of immersion).
These changes in sodium excretion during immer-
sion were associated with a progressive increase in
UKV which returned to preimmersion levels during
the recovery hour. Creatinine clearance remained
constant throughout the studies. During the control
study, a mean gain of 0.2 0.1 kg in body wt was
observed. In contrast, the natriuresis during immer-
sion was associated with a decrease in mean body wt
of 0.9 0.2 kg (P <0.001).
Assays of urines from normal subjects for natri-
uretic activity. The results of individual experiments
with the urine fractions obtained from the same 12
normal subjects during the control studies and the
immersion studies Ofl GFR, UNaV, and FENa in the
rat assay are shown in Table 2. Before infusion of the
fraction, the baseline values for GFR, UNaV, and
FENa in the assay rats used for testing the control vs.
the immersion fractions were comparable and not
statistically different. The mean change in GFR after
infusion of both the control and the immersion frac-
tions was small, inconsistent in direction, and not
statistically significant; nor was there a significant
difference between the changes in GFR between the
two groups (P > 0.5). Following administration of
the urine fraction from the control study, UNaV
increased by a mean of 0.40 0.19 tEq/min, a
change which is not significantly different from zero
and which was comparable to the value for normal
subjects reported previously [8]. A small but signifi-
cant increment in FENa of 0.71 0.25% was
observed (P <0.05). Again, this value was similar to
the LFENa of 0.77 0.39% reported previously in
normal subjects [8]. By contrast, infusion of the
urine fractions from the immersion studies resulted
in significant increments in both UNaV and FENa of
1.27 0.28 [LEq/min and 1.39 0.21%, respectively
(P < 0.001 for postinjection compared to preinjec-
tion values). The changes in both parameters of
sodium excretion were significantly greater than
those induced by the control fractions from the same
patients (P < 0.05).
Figure 2 depicts the mean changes in UNaV and
FENa, expressed as a percentage of preinjection val-
ues, after infusion of the urine fractions from the
control study and the immersion study. With the
urine fractions from the control studies, insignificant
changes in UNaV and FENa were observed (+8.9
3.6 and + 11.7 3.9%, respectively). After infusion
of the urine fraction from the immersion studies,
UNaV increased by a mean of 22.8 4.4%, and FENa
increased by a mean of 25.5 5.2%. Both of these
changes differ significantly from 0 (P < 0.001) and
are significantly different from the changes observed
after infusion of the fractions from the control studies
(P <0.05 for both UNaV and LFENa).
Despite these changes in sodium excretion
induced in the rats by the urine fraction, administra-
tion of the fraction did not alter potassium excretion.
Following administration of the urine fraction from
the control study, UKV was 2.15 0.l2sEq/min, not
Table 2. Effect of urine fraction from normal subjects on GFR and sodium excretion in the rat
Contro1 studies Immersion studies
Before injection After injection Before injection After injection
Patient
no.
GFR
mi/mm
UNaV
EqImin
FENa
%
LGFR
mi/mm
UNaV
p.Eqlmin
FEa
%
GFR
mi/mm
UNaV
pEqimin
FENa
%
LGFR
mi/mm
LUaV
pEqimin
FENa
%
1
2
3
4
5
6
7
8
9
10
11
12
0.65
0.47
1.24
0.24
0.46
0.48
0.75
1.18
0.63
0.61
0.33
0.48
4.62
3.23
8.75
2.50
3.85
5.37
9.52
8.99
6.82
8.80
5.25
3.89
5.23
4.88
5.68
8.68
6.19
8.32
9.22
5.53
8.29
10.49
11.45
5.82
—0.14
0.02
0.02
0.01
0.05
—0.06
—0.07
0.07
—0.12
0.05
0.00
—0.02
—0.10
1.17
1.60
0.26
0.31
0.14
—0.83
0.72
0.52
—0.06
0.16
0.93
1.31
1.47
1.09
0.30
—0.13
0.98
0.16
0.20
2.10
—0.94
0.28
1.68
0.81
0.33
0.75
0.69
0.17
0.67
0.89
0.63
0.92
0.99
0.88
0.92
5.24
5.44
3.60
4.96
1.74
3.31
8.08
6.09
10.21
6.96
6.71
8.13
4.58
12.40
3.78
5.69
8.07
3.57
6.39
7.07
7.99
4.95
5.50
6.30
—0.09
—0.03
—0.10
—0.04
0.10
0.00
—0.01
0.01
0.01
0.01
0.05
0.00
2.83
—0.13
0.74
1.15
0.39
1.00
1.26
0.98
0.52
1.05
2.59
2.88
3.29
1.26
1.55
1.14
0.85
1.10
1.21
1.08
0.63
0.67
1.77
2.14
Mean
SEM
N
0.63
0.09
12
5.97
0.72
12
7.48
0.64
12
—0.02
0.12
12
0.40
0.19
12
0.71
0.25
12
0.72
0.07
12
5.87
0.68
12
6.36
0.69
12
—0.01
0.01
12
l.27
0.28
12
13,b
0.21
12
a p <0.05 for postinjection periods compared to preinjection periods.
P < 0.05 for immersion studies compared to control studies.
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different from the preinjection value of 2.32
0. l4pEq/min (P > 0.3). Similarly, administration of
the urine fraction from the immersion study resulted
in a mean UKV of 2.56 0. l2pFq/min, not different
from the preinjection value of 2.61 0.15.tEq/min
(P > 0.3 for post-injection compared to preinjection
values).
Discussion
Water immersion to the neck has been shown
previously to produce a marked natriuresis [1, 2]
which is quantitatively identical to that produced by
a 10% expansion of extracellular fluid volume with
isotonic saline [14]. The natriuresis of immersion
occurs independently of changes in GFR [6]. It also
has been demonstrated that the administration of
pharmacologic doses of a potent mineralocorticoid
hormone diminishes but does not abolish the natri-
uresis of water immersion, thus demonstrating that
suppression of aldosterone did not account com-
pletely for the natriuresis of immersion [2].
Several lines of evidence have suggested the pres-
ence of a circulating inhibitor of sodium transport in
animals and man subjected to extracellular fluid vol-
ume expansion [9, 10, 15-20]. Recent studies have
also raised the theoretical possibility that a humoral
natriuretic factor could play a role in the physiologi-
cal events responsible for the natriuresis of water
immersion [2]. Thus, it was observed that the natri-
uresis continued during the recovery hour after
water immersion, despite the fact that the sodium
and fluid loss during immersion had led to progres-
sive volume contraction [2]. This delay in the disap-
pearance of the natriuresis is compatible with the
presence of a humoral factor, rather than with more
rapidly acting hemodynamic and/or neural mecha-
nisms which may contribute to the natriuresis. The
present study demonstrates that urine fractions from
normal subjects undergoing immersion produced a
significant increase in EJNaV and FENa in rats when
using a standard bioassay procedure.
—-
Since previous studies have demonstrated that
immersion suppresses both plasma aldosterone [5]
and urinary excretion of aldosterone [2], it is impor-
tant to consider the possibility that the differing natri-
uretic effects of the control and immersion urine
fractions were attributable to differences in their con-
tent of aldosterone. The current demonstration that
the UKV responses induced by the control and
immersion fraction did not differ, and the demonstra-
tion that the natriuresis occurred promptly after the
administration of the urine fraction render this possi-
bility highly unlikely. Thus, the results of the present
study suggest that the natriuretic effect of the immer-
sion urine fractions is indeed attributable to a natri-
uretic factor and not to differences in mineralocorti-
coid content.
Previous studies have demonstrated the presence
of a low molecular weight circulating inhibitor of
sodium transport with natriuretic activity in the plas-
ma and urine of chronically uremic patients [7, 8]
and dogs [9]. This observation, however, does not
per se establish the inhibitor as a physiologic modu-
lator of sodium excretion in uremia. Although it
could contribute to the enhanced natriuresis per
nephron seen in chronic uremia, its presence may
merely be fortuitous. In order to postulate that such
a natriuretic factor contributes to the modulation of
sodium excretion in health, it was necessary to dem-
onstrate the presence of such a factor in nonuremic
healthy individuals.
Several laboratories have recently reported that a
low molecular weight circulating natriuretic factor
was also demonstrable in nonuremic animal models.
Buckalew and Lancaster [10] have demonstrated the
presence of an inhibitor of toad bladder sodium
transport in the plasma of dogs undergoing "escape"
from chronic desoxycorticosterone acetate (DOCA)
administration, although Brown et al [21] were una-
ble to confirm these findings. Favre et al [9] have
demonstrated recently the presence of an inhibitor of
sodium transport in the urine of dogs undergoing
mineralocorticoid escape, which inhibited short-cir-
cuit current in the toad bladder and produced a
natriuresis in the rat. Clarkson, Raw, and de Warde-
ner [19] have reported similar observations with
urine fractions of man maintained on a high oral
sodium intake. The results of the present study
extend these earlier observations and demonstrate
the presence of a natriuretic factor in the urine of
normal subjects undergoing a water immersion-
UN,V FENa
130
C0
0
a)
C
a)
a.
0
control Immersion control Immersion
Study fractions
Fig. 2. Effect qf urine fractions othained from normal subjects
during coatrol and water immersion studies on GFR and sodium
excretion in the assay rat. The fractions from the immersion
studies resulted in significant increases in both UNaV and FENa,
exceeding the changes observed with the control study fractions
(P < 0.05).
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induced natriuresis. Although the chemical identity
of the natriuretic factors present in the urine of
patients with chronic uremia, or normal dogs during
mineralocorticoid escape, and in the present experi-
ments has not been established, their similar elution
pattern on column chromatography suggests that the
natriuretic activity in these fractions, obtained under
these differing experimental conditions, may relate
to the same substance. If the chemical identity of the
present natriuretic factor is identical to that of the
natriuretic factor(s) described in other experimental
models, the current study lends strong support to the
concept that a natriuretic factor may constitute part
of the effector limb of the physiologic control system
regulating sodium excretion in normal man.
Many other attempts to demonstrate a natriuretic
factor utilized acute saline-loading as an experimen-
tal maneuver [15, 18, 20, 22]. As pointed out by
Levinsky in a critical review [23], acute saline-load-
ing induces large changes in blood composition
which may confound the interpretation of many stud-
ies purporting to demonstrate the existence of a
humoral natriuretic factor. While previous investiga-
tors have successfully volume-expanded animals
while avoiding dilutional changes [24-28], these
investigators employed techniques involving cross-
circulation [24, 26, 28] or perfusing an isolated kid-
ney [25, 27] in experimental animals other than man.
In contrast, water immersion constitutes a relatively
simple and nonhazardous means of attaining volume
expansion without concomitant alterations in blood
composition [1, 2], and is thus applicable to man.
Thus, the current study extends previous demonstra-
tions in nonhuman models [24-29] and supports the
hypothesis that the appearance of natriuretic factor
during immersion is indeed a response to volume
expansion.
Finally, the results of the present study may pro-
vide additional insights into the nature of the volume
receptors which serve as the afferent mechanism for
the regulation of natriuretic factor. Although pre-
vious studies have suggested that saline administra-
tion was associated with an increase in natriuretic
factor, such a manipulation is associated with an
expansion of the total ECF with parallel increases in
the interstitial, venous, capillary, and arterial vol-
umes. In contrast, immersion is associated with a
contraction of total ECF volume with preferential
augmentation of the thoracic venous return and
increase in central blood volume [3, 4]. The demon-
stration for the first time of an increased activity of
natriuretic factor in association with water immer-
sion suggests that volume receptors located centrally
in the intrathoracic region may constitute part of the
afferent limb of the biologic control system whereby
natriuretic factor participates in regulating sodium
homeostasis. Such an interpretation is consistent
with recent studies by Ackermann and Pearce [301
These workers studied the natriuretic and diuretic
response to isotonic, iso-oncotic blood volume
expansion in rats and noted that the resultant natri-
uresis did not lead to a correction of the expanded
extracellular fluid or blood volume. Nevertheless,
regardless of the preexpansion volume status, the
natriuresis abated when the animals' elevated mean
central venous pressure had returned to its preinfu-
sion level. These results suggest that the control of
central venous pressure, or some associated varia-
ble, may be the major determinant of the renal
response to volume expansion in the rat.
In summary, the results of the present study dem-
onstrate that urine fractions from normal subjects
undergoing immersion, when infused into assay rats
with a reduced GFR, cause a significant increment in
both absolute and fractional sodium excretion. These
observations are consistent with the suggestion that
increased levels of natriuretic factor mediate at least
in part, the natriuresis of immersion. Finally, it is
suggested that water immersion may constitute an
appropriate investigative tool for elucidating further
the role of natriuretic factor in regulating sodium
homeostasis in man.
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